癌症
医学
肿瘤科
内科学
重症监护医学
梅德林
疾病
生物信息学
癌症研究
免疫学
作者
Zirui Zhu,Jocelyn Mathew,Benjamin Barrett,Hejia Henry Wang,Amanda L. Huff,Todd D. Armstrong,Elizabeth M. Jaffee,Neeha Zaidi
标识
DOI:10.1016/j.molmed.2026.02.004
摘要
Intercepting cancer development with immune-modulating approaches before cancer has established is an emerging and promising strategy to reduce the global cancer burden. By safely harnessing the immune system, cancer vaccines can enhance immune surveillance and lead to the elimination of transforming cells at the earliest stages of carcinogenesis, particularly when the immune microenvironment is least hostile and the potential for cure is greatest. In this review, we discuss the fundamental rationale behind immuno-interception strategies, provide an overview of advances in cancer interception clinical trials, and highlight key considerations and future directions for achieving effective cancer interception.
科研通智能强力驱动
Strongly Powered by AbleSci AI